The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

How to treat the left main

The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation

EuroIntervention 2015;11:V115-V119. DOI: 10.4244/EIJV11SVA26

1. Erasmus University Medical Center, Rotterdam, The Netherlands; 2. Heart Institute (InCor), University of São Paulo Medical School, Sao Paulo, Brazil; 3. Department of Cardiology, B Aarhus University Hospital, Skejby, Denmark; 4. Columbia University Med

Unprotected left main coronary artery (ULMCA) stenosis has relatively high prevalence and exposes patients to a high risk for adverse cardiovascular events. The optimal revascularisation strategy (coronary artery bypass surge

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
When and how to perform the provisional approach for distal LM stenting